Pink Sheet Podcast: US FDA In A Biden Administration, Aducanumab’s Adcomm Failure
Citeline Podcasts - A podcast by Citeline
Categories:
Pink Sheet reporters and editor discuss the potential changes at the FDA under President-elect Biden and the take-aways from the negative advisory committee recommendation for Biogen’s proposed Alzheimer’s drug aducanumab.
